CRDL – CFN Media

Ventyx/Lilly Deal Shows the Value of Anti-inflammatory Drugs

We wrote late last year about the recent upswing in big pharma…

Robin Lefferts
January 15, 2026

Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx™ in Acute Myocarditis

Toronto, Ontario–(Newsfile Corp. – August 6, 2025) – Cardiol Therapeutics Inc. (NASDAQ: CRDL)…

Ryan Allway
August 6, 2025

Former Eli Lilly CMO Joins Cardiol’s Board, Bolstering Drug Development, Clinical Trial, and Commercial Expertise

As smaller clinical stage pharmaceutical companies advance drug candidates from the lab…

Robin Lefferts
May 29, 2025

Distinguished Health Centers and Experts Lead Recurrent Pericarditis, Acute Myocarditis Clinical Trials

Any clinical trial program relies heavily on its administrators, advisors, and designers.…

Robin Lefferts
January 16, 2024

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Stella Emory

Wilson Augustine

New Micro-Cap Entrant into GLP-1 Space Offers Early-Entry Opportunity to Rival Market Leaders

For most investors, the GLP‑1 story starts and ends with Novo Nordisk…

Wilson Augustine
May 12, 2026

Mining Stocks

LaFleur Expands Swanson Gold Deposit System, Confirming Strong Continuity with 2.95 g/t Au over 80.00 metres and 2.37 g/t Au over 88.05 metres

VANCOUVER, BC – May 12, 2026, LaFleur Minerals Inc. (CSE: LFLR, OTCQB: LFLRF,…

Ryan Allway
May 12, 2026

Mining Stocks

Advanced Gold Exploration Dispatches 87 Samples from 2026 Mapping and Reconnaissance Program, at Silver Belle Project, Nevada

Vancouver, British Columbia–(Newsfile Corp. – May 12, 2026)…

Ryan Allway
May 12, 2026

Mining Stocks

LaFleur Minerals Engages Leading Executive Search Firm to Recruit Senior Mining Executive as Company Advances Toward Gold Production

VANCOUVER, British Columbia, May 08, 2026 (GLOBE…

Ryan Allway
May 8, 2026